CATALOG NO | PRODUCT NAME | CAS | PURITY | STRUCTURE |
---|---|---|---|---|
18381 | JPH203 HCl ( Nanvuranlat ) | 1597402-27-1 | ≧98.0% | ![]() |
JPH203,也称为KYT- 0353,是一个强有力的和选择性(l型氨基酸转运蛋白 | ||||
1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% | ![]() |
Anlotinib也被称为AL3818,是一种受体酪氨酸激酶(RTK)抑制剂,具有潜 | ||||
21257 | Difelikefalin | 1024828-77-0 | ≧98.0% | ![]() |
Difelikefalin HCl is in stock.Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is | ||||
20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% | ![]() |
Elinzanetant,以前称为 NT-814 (45),是一种双重 NK1,3R 拮抗剂,因此有 | ||||
20266 | Linzagolix | 935283-04-8 | ≧98.0% | ![]() |
Linzagolix 是一种新型的口服 GnRH 受体拮抗剂,可有效治疗子宫内膜 | ||||
21075 | 1-cyanocyclohexyl 4-methylbenzenesulfonate | 90775-01-2 | ≧98.0% | ![]() |
1-cyanocyclohexyl 4-methylbenzenesulfonate (CAS 90775-01-2 ) 是有机合成反应中 | ||||
20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% | ![]() |
SRI-37330 hydrochloride 是一种新型 TXNIP 表达抑制剂,呈剂量依赖性抑 | ||||
18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | ![]() |
Ritlecitinib ( PF-06651600 )是一种有效的选择性JAK3抑制剂,是一种具有 | ||||
2091204 | 2,4-二甲基-5-羟基嘧啶 | 412003-95-3 | ≧96.0% | ![]() |
我们可以生产公斤级的2,4-二甲基-5-羟基嘧啶 (CAS 412003-95-3)。 | ||||
16122809 | 依拉司群 | 722533-56-4 | ≧98.0% | ![]() |
依拉司群(Elacestrant), also known as RAD1901, is an orally available, selective e | ||||
20265 | Daridorexant ( ACT541468 ) | 1505484-82-1 | ≧98.0% | ![]() |
Daridorexant 是一种双重食欲素受体拮抗剂 (DORA),专为治疗失眠而设 | ||||
20273 | Delgocitinib(JTE-052) | 1263774-59-9 | ≧98.0% | ![]() |
Delgocitinib,也称为 LEO-124249 和 JTE052,是一种有效的选择性 JAK 抑制 |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2021 Sun-shine Chem All rights reserved.